0001104659-24-030148.txt : 20240301 0001104659-24-030148.hdr.sgml : 20240301 20240301203012 ACCESSION NUMBER: 0001104659-24-030148 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240228 FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAY WILLIAM GARRETT CENTRAL INDEX KEY: 0001692961 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38128 FILM NUMBER: 24712539 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc. CENTRAL INDEX KEY: 0001651407 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472568632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 95 SAWYER ROAD STREET 2: SUITE 110 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 95 SAWYER ROAD STREET 2: SUITE 110 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 tm247659-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-28 0 0001651407 Checkpoint Therapeutics, Inc. CKPT 0001692961 GRAY WILLIAM GARRETT 95 SAWYER RD, SUITE 110 WALTHAM MA 02453 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-02-28 4 S 0 2035 2.07 D 145224 D In connection with the vesting of 3,925 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Gray's tax withholding obligations. Mr. Gray had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $2.07 to $2.075. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Includes shares of restricted common stock, which vest over various time periods. /s/ Garrett Gray 2024-03-01